Bioloomics, Inc.
bioloomics is a preclinical stage biotechnology company leveraging directed evolution of antibodies in human cells to create adcs with improved internalization and trafficking. our proprietary tech combines single-cell bioassay engineering, robotics, and ml. #synbio #directedevolution #antibodies #adcs
Last updated on
About Bioloomics, Inc.
Founded
2019Employees
11-50Funding / Mkt. Cap
$10MCategory
Industry
BiotechnologyLocation
City
BoulderState
ColoradoCountry
United StatesBioloomics, Inc.
Find your buyer within Bioloomics, Inc.